• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的射血分数保留的心力衰竭评分与对比剂肾病

HFPEF Score and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

作者信息

Ozbeyaz Nail Burak, Gokalp Gokhan, Algul Engin, Sahan Haluk Furkan, Aydinyilmaz Faruk, Guliyev Ilkin, Kalkan Kamuran

机构信息

Pursaklar State Hospital, 37511Department of Cardiology Clinic, Ankara, Turkey.

University of Health Sciences, 146992Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

出版信息

Angiology. 2023 Feb;74(2):181-188. doi: 10.1177/00033197221099425. Epub 2022 May 3.

DOI:10.1177/00033197221099425
PMID:35503102
Abstract

Contrast-induced nephropathy (CIN) is one of the most common complications associated with coronary angiography and percutaneous coronary intervention (PCI). This study evaluated the relationship between the HFPEF (obesity (H), hypertension(H), atrial fibrillation (F), pulmonary hypertension (P), an age >60 years (E), and E/e' > 9 (F)) score which is used to diagnose heart failure with preserved ejection fraction and CIN. Patients (n = 1346) who underwent PCI for acute coronary syndrome (ACS) between December 2018 and January 2021 were retrospectively included. Contrast-induced nephropathy patients had significantly higher HFPEF scores (4.10 ± 1.92 vs 2.28 ± 1.56, P < .001). In addition, the HFPEF score was found to be an independent risk factor for the development of CIN (Odd Ratio 1.633 95% CI (1.473-1.811), P < .001) together with age, diabetes mellitus, systolic pulmonary arterial pressure, and left anterior descending as an infarct-related artery. According to point biserial correlation analysis, CIN and HFPEF score have a strong correlation (r = .376, P < .001). The receiver operating characteristic curve showed the optimal cutoff value of the HFPEF score to predict the development of CIN was 2.5, with 79.8% sensitivity and 64.1% specificity. In conclusion, the HFPEF score may predict the development of CIN in patients presenting with ACS and undergoing PCI.

摘要

造影剂肾病(CIN)是冠状动脉造影和经皮冠状动脉介入治疗(PCI)相关的最常见并发症之一。本研究评估了用于诊断射血分数保留的心力衰竭的HFPEF(肥胖(H)、高血压(H)、心房颤动(F)、肺动脉高压(P)、年龄>60岁(E)和E/e'>9(F))评分与CIN之间的关系。回顾性纳入了2018年12月至2021年1月期间因急性冠状动脉综合征(ACS)接受PCI的患者(n = 1346)。造影剂肾病患者的HFPEF评分显著更高(4.10±1.92 vs 2.28±1.56,P<.001)。此外,发现HFPEF评分与年龄、糖尿病、收缩期肺动脉压以及作为梗死相关动脉的左前降支一起是CIN发生的独立危险因素(比值比1.633,95%CI(1.473 - 1.811),P<.001)。根据点二列相关分析,CIN与HFPEF评分具有强相关性(r = 0.376,P<.001)。受试者工作特征曲线显示,预测CIN发生的HFPEF评分最佳截断值为2.5,敏感性为79.8%,特异性为64.1%。总之,HFPEF评分可能预测ACS患者接受PCI时CIN的发生。

相似文献

1
HFPEF Score and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的射血分数保留的心力衰竭评分与对比剂肾病
Angiology. 2023 Feb;74(2):181-188. doi: 10.1177/00033197221099425. Epub 2022 May 3.
2
CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.CHA2DS2-VASc评分作为急性冠状动脉综合征经皮冠状动脉介入治疗后对比剂肾病的新型预测指标。
Indian Heart J. 2019 Jul-Aug;71(4):303-308. doi: 10.1016/j.ihj.2019.09.005. Epub 2019 Sep 9.
3
Association of the blood urea nitrogen-to-left ventricular ejection fraction ratio with contrast-induced nephropathy in patients with acute coronary syndrome who underwent percutaneous coronary intervention.血尿素氮与左心室射血分数比值与行经皮冠状动脉介入治疗的急性冠状动脉综合征患者对比剂肾病的关系。
Int Urol Nephrol. 2019 Mar;51(3):475-481. doi: 10.1007/s11255-018-2052-1. Epub 2019 Jan 2.
4
The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction.ST段抬高型心肌梗死患者中H2FPEF评分与造影剂肾病的关系。
J Cardiovasc Thorac Res. 2022;14(4):240-245. doi: 10.34172/jcvtr.2022.30537. Epub 2022 Dec 24.
5
Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.复杂经皮冠状动脉介入治疗患者对比剂肾病的风险。
Int J Cardiol. 2019 Sep 1;290:59-63. doi: 10.1016/j.ijcard.2019.04.043. Epub 2019 Apr 14.
6
Relationship between thiol, disulphide volume and contrast-induced nephropathy in acute coronary syndrome patients treated with percutaneous coronary intervention.经皮冠状动脉介入治疗急性冠脉综合征患者巯基、二硫键体积与对比剂诱导肾病的关系。
Scand J Clin Lab Invest. 2021 May;81(3):173-180. doi: 10.1080/00365513.2021.1878386. Epub 2021 Feb 2.
7
Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.红细胞分布宽度可预测急性冠状动脉综合征患者接受经皮冠状动脉介入治疗时发生的对比剂肾病。
Angiology. 2015 May;66(5):433-40. doi: 10.1177/0003319714535238. Epub 2014 May 16.
8
The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.肾阻力指数对急性冠脉综合征患者对比剂肾病的预测价值。
BMC Cardiovasc Disord. 2019 Feb 11;19(1):36. doi: 10.1186/s12872-019-1017-3.
9
Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.急性冠状动脉综合征经皮冠状动脉介入治疗后CHA2DS2-VASC评分对造影剂肾病的预测价值
Am J Cardiol. 2017 Mar 15;119(6):819-825. doi: 10.1016/j.amjcard.2016.11.033. Epub 2016 Dec 18.
10
Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.加拿大急性冠状动脉综合征评分:直接经皮冠状动脉介入治疗后对比剂肾病的术前风险评分。
Angiology. 2017 Oct;68(9):782-789. doi: 10.1177/0003319717690674. Epub 2017 Jan 31.

引用本文的文献

1
The impact of preprocedural pulmonary artery systolic pressure on acute kidney injury related to transcatheter aortic valve replacement.术前肺动脉收缩压对经导管主动脉瓣置换术相关急性肾损伤的影响。
Postepy Kardiol Interwencyjnej. 2025 Mar;21(1):88-93. doi: 10.5114/aic.2025.148178. Epub 2025 Mar 12.
2
Baseline level of interleukin-6 is associated with the risk of acute coronary syndrome development in SARS-CoV-2 infection.白细胞介素-6 的基线水平与 SARS-CoV-2 感染后急性冠状动脉综合征发展的风险相关。
BMC Cardiovasc Disord. 2024 Oct 12;24(1):550. doi: 10.1186/s12872-024-04234-x.
3
Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHADS-VAS Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism.
血小板与淋巴细胞比值联合CHADS-VAS评分对非瓣膜性心房颤动所致心源性脑栓塞的预后价值
J Inflamm Res. 2023 Dec 6;16:5937-5947. doi: 10.2147/JIR.S431149. eCollection 2023.
4
Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome.血清胱抑素 C 可预测非 ST 段抬高型急性冠状动脉综合征的风险。
J Cardiothorac Surg. 2023 Dec 1;18(1):351. doi: 10.1186/s13019-023-02465-1.
5
Risk stratification algorithm for clinical outcomes in anemic patients undergoing percutaneous coronary intervention.贫血患者行经皮冠状动脉介入治疗的临床结局风险分层算法。
Ann Med. 2023;55(2):2249200. doi: 10.1080/07853890.2023.2249200.
6
Normal thyroid stimulating hormone is associated with all-cause mortality in patients with acute myocardial infarction after percutaneous coronary intervention.正常的促甲状腺激素与经皮冠状动脉介入治疗后急性心肌梗死后患者的全因死亡率相关。
Eur J Med Res. 2023 Jun 29;28(1):199. doi: 10.1186/s40001-023-01149-9.
7
Contrast-induced nephropathy prediction following ST-elevation myocardial infarction: Missing links.ST段抬高型心肌梗死后对比剂诱导的肾病预测:缺失环节
J Cardiovasc Thorac Res. 2023;15(1):67. doi: 10.34172/jcvtr.2023.31706. Epub 2023 Mar 16.